Cadrenal Therapeutics
CVKD
#9731
Rank
NZ$54.65 M
Marketcap
$28.17
Share price
-1.18%
Change (1 day)
158.62%
Change (1 year)

EPS for Cadrenal Therapeutics (CVKD)

EPS in 2024 (TTM): -$11.33

According to Cadrenal Therapeutics's latest financial reports the company's current EPS (TTM) is -$11.64. In 2023 the company made an earnings per share (EPS) of -$15.58.

EPS history for Cadrenal Therapeutics from 2023 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-$11.33-27.3%
2023-$15.58